GENZYME CORP Cash and Cash Equivalents
GENZYME CORP had Cash and Cash Equivalents of $1.33 billion as of 2010-12-31, per its 10-K filed 2011-03-01.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2011-03-01
- 2010-12-31: Cash and Cash Equivalents, at Carrying Value $1.33B.
- 2010-09-30: Cash and Cash Equivalents, at Carrying Value $899.16M.
- 2010-06-30: Cash and Cash Equivalents, at Carrying Value $681.81M.
- 2010-03-31: Cash and Cash Equivalents, at Carrying Value $643.34M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2010-12-31 | $1.33B 10-K · filed 2011-03-01 |
| 2010-09-30 | $899.16M 10-Q · filed 2010-11-09 |
| 2010-06-30 | $681.81M 10-Q/A · filed 2010-09-07 |
| 2010-03-31 | $643.34M 10-Q/A · filed 2010-05-11 |
| 2009-12-31 | $742.25M 10-K · filed 2011-03-01 |
| 2009-09-30 | $679.56M 10-Q · filed 2010-11-09 |
| 2009-06-30 | $731.93M 10-Q/A · filed 2010-09-07 |
| 2009-03-31 | $643.44M 10-Q/A · filed 2010-05-11 |
| 2008-12-31 | $572.11M 10-K · filed 2011-03-01 |
| 2008-09-30 | $918.74M 10-Q · filed 2009-11-02 |
| 2008-06-30 | $693.69M 10-Q/A · filed 2009-09-04 |
| 2007-12-31 | $867.01M 10-K · filed 2011-03-01 |
| 2006-12-31 | $492.17M 8-K · filed 2010-06-14 |